Home Analysis of the CAG tract length in the Androgen Receptor gene in Mexican patients with nonsyndromic cryptorchidism
Article
Licensed
Unlicensed Requires Authentication

Analysis of the CAG tract length in the Androgen Receptor gene in Mexican patients with nonsyndromic cryptorchidism

  • Daniel A. Landero-Huerta , Rosa M. Vigueras-Villaseñor , Lucía Taja-Chayeb , Fabiola García-Andrade , Elena Aréchaga-Ocampo , Emiy Yokoyama-Rebollar , José Díaz-Chávez , Luis A. Herrera and Margarita D. Chávez-Saldaña ORCID logo EMAIL logo
Published/Copyright: April 12, 2021

Abstract

Objectives

Cryptorchidism is the most common genitourinary birth defect in live newborn males and is considered as an important risk factor for testicular germ cell tumors and infertility. The Androgen Receptor gene is important in this pathology due to its participation, mainly, in the inguinoscrotal phase of testicular descent. We determine the length of the CAG tract in the Androgen Receptor (AR) gene in Mexican patients with nonsyndromic cryptorchidism.

Methods

One hundred and 15 males were included; of these, 62 had nonsyndromic cryptorchidism and 53 were healthy volunteers. DNA was extracted from a peripheral blood samples, subsequently, the CAG tract in exon 1 of AR gene was amplified by PCR and sequenced.

Results

Mexican patients with nonsyndromic cryptorchidism presented 25.03 ± 2.58 repeats of CAG tract in the AR gene compared to 22.72 ± 3.17 repeats of CAG tract in Mexican healthy individuals (p≤0.0001; t value of 4.3). Furthermore, the deletion of codon 57 that corresponds to the deletion of a leucine residue at position 57 (Del L57) in the AR gene was found for the first time in a nonsyndromic cryptorchidism patient. This molecular alteration has been related previously to testicular germ cell tumor (TGCT).

Conclusions

The CAG tract in the AR gene is longer in patients with nonsyndromic cryptorchidism than in healthy individuals, supporting the association between this polymorphism of the AR gene and nonsyndromic cryptorchidism in the Mexican population.


Corresponding author: Margarita Chávez-Saldaña, Laboratorio de Biología de la Reproducción, Instituto Nacional de Pediatría, Av. Insurgentes Sur 3700- C, Col. Insurgentes-Cuicuilco, C.P. 04530 Ciudad de México, México, Phone (+52) (55) 1084 0900 Ext. 1453, Fax: (+52) (55) 1084 5533, E-mail:

Funding source: Instituto Nacional de Pediatría (INP)

Funding source: CONACyT FOSISS

Award Identifier / Grant number: 272641

Acknowledgements

CONACyT for the scholarship granted to Daniel Adrian Landero Huerta (No. 429258). Daniel Landero submitted this article to fulfill the graduate requirements for PhD degree program at Posgrado en Ciencias Naturales e Ingeniería of Universidad Autónoma Metropolitana, Unidad Cuajimalpa.

  1. Research funding: CONACyT FOSISS (Project number 272641) and Instituto Nacional de Pediatría (INP): 01/2016.

  2. Author contributions: Conception and design MDCHS, RMVV; Acquisition of data DALH, EYR, JDCH, LAH; Analysis and Interpretation of data DALH, LTCH, EAO, EYR, JDCH, LAH, MDCHS; Drafting of the manuscript DALH, MDCHS; Critical revision of the manuscript for important intellectual content DALH, RMVV, LTCH, FGA, EAO, EYR, JDCH, LAH, MDCHS; Statistical analysis DALH, FGA, Obtaining funding MDCHS, RMVV, Administrative, technical or material support DALH, LTCH, FGA, Supervision MDCHS, RMVV.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: This study is part of the project with registration number INP-01/2016, which was approved by the Instituto Nacional de Pediatría Ethical and Research Committees.

References

1. Sinopidis, X, Mourelatou, R, Kostopoulou, E, Karvela, A, Rojas-Gil, A, Tsekoura, E, et al.. Novel combined insulin-like 3 variations of a single nucleotide in cryptorchidism. J Pediatr Endocrinol Metab 2019;32:987–94.10.1515/jpem-2018-0547Search in Google Scholar PubMed

2. Foresta, C, Zuccarello, D, Garolla, A, Ferlin, A. Role of hormones, genes, and environment in human cryptorchidism. Endocr Rev 2008;29:560–80.10.1210/er.2007-0042Search in Google Scholar PubMed

3. Barthold, J, Ivell, R. Perspective: a neuro-hormonal systems approach to understanding the complexity of cryptorchidism susceptibility. Front Endocrinol 2018;9.10.3389/fendo.2018.00401Search in Google Scholar PubMed PubMed Central

4. Davis-Dao, C, Koh, C, Hardy, B, Chang, A, Kim, S, De Filippo, R, et al.. Shorter Androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boys. J Clin Endocrinol Metab 2012;97:E393–9.10.1210/jc.2011-2439Search in Google Scholar PubMed

5. Wang, Q, Ge, X, Wang, H, Shi, Q, Ding, Z, Xu, L. Association of androgen receptor gene CAG and GGN repeat polymorphism with cryptorchidism: a meta-analysis. Andrologia 2017;50:e12909.10.1111/and.12909Search in Google Scholar PubMed

6. Silva-Ramos, M, Oliveira, J, Cabeda, J, Reis, A, Soares, J, Pimenta, A. The CAG repeat within the androgen receptor gene and its relationship to cryptorchidism. Int Braz J Urol 2006;32:330–5.10.1590/S1677-55382006000300014Search in Google Scholar

7. Ferlin, A, Garolla, A, Bettella, A, Bartoloni, L, Vinanzi, C, Roverato, A, et al.. Androgen receptor gene CAG and GGC repeat lengths in cryptorchidism. Eur J Endocrinol 2005;152:419–25.10.1530/eje.1.01860Search in Google Scholar PubMed

8. Garolla, A, Ferlin, A, Vinanzi, C, Roverato, A, Sotti, G, Artibani, W, et al.. Molecular analysis of the androgen receptor gene in testicular cancer. Endocr Relat Canc 2005;12:645–55.10.1677/erc.1.00954Search in Google Scholar PubMed

9. Davis-Dao, C, Siegmund, K, Vandenberg, D, Skinner, E, Coetzee, G, Thomas, D, et al.. Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types. Carcinogenesis 2011;32:1238–43.10.1093/carcin/bgr104Search in Google Scholar PubMed PubMed Central

10. Västermark, Å, Giwercman, Y, Hagströmer, O, De-Meyts, E, Eberhard, J, Ståhl, O, et al.. Polymorphic variation in the androgen receptor gene: association with risk of testicular germ cell cancer and metastatic disease. Eur J Canc 2011;47:413–9.10.1016/j.ejca.2010.08.017Search in Google Scholar PubMed

11. Gelmann, E. Molecular biology of the androgen receptor. J Clin Oncol 2002;20:3001–15.10.1200/JCO.2002.10.018Search in Google Scholar

12. Grassetti, D, Giannandrea, F, Paoli, D, Masciandaro, P, Figura, V, Carlini, T, et al.. Androgen receptor polymorphisms and testicular cancer risk. Andrology 2014;3:27–33.10.1111/j.2047-2927.2014.00252.xSearch in Google Scholar

13. Nenonen, H, Björk, C, Skjaerpe, P, Giwercman, A, Rylander, L, Svartberg, J, et al.. CAG repeat number is not inversely associated with androgen receptor activity in vitro. Mol Hum Reprod 2009;16:153–7.10.1093/molehr/gap097Search in Google Scholar

14. Aschim, E, Nordenskjöld, A, Giwercman, A, Lundin, K, Ruhayel, Y, Haugen, T, et al.. Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. J Clin Endocrinol Metab 2004;89:5105–9.10.1210/jc.2004-0293Search in Google Scholar

15. Giagulli, V, Carbone, M, De Pergola, G, Guastamacchia, E, Resta, F, Licchelli, B, et al.. Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility? J Assist Reprod Genet 2014;31:689–97.10.1007/s10815-014-0221-4Search in Google Scholar

16. Kumar, R, Atamna, H, Zakharov, M, Bhasin, S, Khan, S, Jasuja, R. Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy. Life Sci 2011;88:565–71.10.1016/j.lfs.2011.01.021Search in Google Scholar

17. Gómez, R, Torres-Sánchez, L, Camacho-Mejorado, R, Burguete-García, A, Vázquez-Salas, R, Martínez-Nava, G, et al.. Androgen receptor CAG polymorphism and sporadic and early-onset prostate cancer among Mexican men. J Hum Genet 2016;61:781–6.10.1038/jhg.2016.49Search in Google Scholar

18. Sánchez, B, Aguayo, A, Martínez, B, Rodríguez, F, Marmolejo, M, Svyryd, Y, et al.. Using genetic and epigenetic markers to improve differential diagnosis of prostate cancer and benign prostatic hyperplasia by noninvasive methods in Mexican patients. Clin Genitourin Canc 2018;16:e867–77.10.1016/j.clgc.2018.02.004Search in Google Scholar

19. Dang, J, Peng, L, Zhong, H, Huo, Z. Androgen receptor (CAG)n polymorphisms and breast cancer risk in a Han Chinese population. Genet Mol Res 2015;14:10258–66.10.4238/2015.August.28.10Search in Google Scholar

20. Ferro, P, Catalano, M, Dell’Eva, R, Fortunati, N, Pfeffer, U. The androgen receptor CAG repeat: a modifier of carcinogenesis? Mol Cell Endocrinol 2002;193:109–20.10.1016/S0303-7207(02)00104-1Search in Google Scholar

21. Mobasseri, N, Babaei, F, Karimian, M, Nikzad, H. Androgen receptor (AR)-CAG trinucleotide repeat length and idiopathic male infertility: a case-control trial and a meta-analysis. EXCLI J 2018;17:1167–79.Search in Google Scholar

22. Nenonen, H, Giwercman, A, Hallengren, E, Giwercman, Y. Non.linear association between androgen receptor CAG repeat length and risk of male subfertility –a meta-analisis. Int J Androl 2010;34:327–32.10.1111/j.1365-2605.2010.01084.xSearch in Google Scholar PubMed

23. Sasagawa, I. CAG repeat length of the androgen receptor gene in Japanese males with cryptorchidism. Mol Hum Reprod 2000;6:973–5.10.1093/molehr/6.11.973Search in Google Scholar PubMed

24. Skakkebaek, N, Rajpert-De Meyts, E, Buck Louis, G, Toppari, J, Andersson, A, Eisenberg, M, et al.. Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol Rev 2016;96:55–97.10.1152/physrev.00017.2015Search in Google Scholar PubMed PubMed Central

25. Ackerman, C, Lowe, L, Lee, H, Hayes, M, Dyer, A, Metzger, B, et al.. Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat. J Androl 2011;33:210–5.10.2164/jandrol.111.013391Search in Google Scholar PubMed PubMed Central

26. Arteaga-Vázquez, J, López-Hernández, M, Svyryd, Y, Mutchinick, O. Lack of concordance and linkage disequilibrium among brothers for androgenetic alopecia and CAG/GGC haplotypes of the androgen receptor gene in Mexican families. J Cosmet Dermatol 2015;14:268–73.10.1111/jocd.12159Search in Google Scholar PubMed

27. Castro-Nallar, E, Bacallao, K, Parada-Bustamante, A, Lardone, M, Lopez, P, Madariaga, M, et al.. Androgen receptor gene CAG and GGN repeat polymorphisms in Chilean men with primary severe spermatogenic failure. J Androl 2010;31:552–9.10.2164/jandrol.109.008821Search in Google Scholar PubMed

28. Wang, Y, Wei, Y, Tang, X, Liu, B, Shen, L, Long, C, et al.. Association between androgen receptor polymorphic CAG and GGC repeat lengths and cryptorchidism: a meta-analysis of case-control studies. J Pediatr Urol 2018;14:432.e1–9.10.1016/j.jpurol.2018.05.011Search in Google Scholar PubMed

29. Huang, G, Shan, W, Zeng, L, Huang, L. Androgen receptor gene CAG repeat polymorphism and risk of isolated hypospadias: results from a meta-analysis. Genet Mol Res 2015;14:1580–8.10.4238/2015.March.6.5Search in Google Scholar PubMed

30. Gu, X, Qin, J, Cui, N, Hou, R, Liu, T, Sun, H, et al.. Association between androgen receptor gene polymorphisms and testicular germ cell tumor: a systematic review and meta-analysis. J Canc Res Therapeut 2019;15:60.10.4103/0973-1482.181175Search in Google Scholar PubMed

Received: 2020-06-24
Accepted: 2021-03-05
Published Online: 2021-04-12
Published in Print: 2021-07-27

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. Delivery factors and neonatal thyroid hormone levels: a systematic review
  4. Original Articles
  5. Birth prevalence of tetrahydrobiopterin deficiency in China: data from the national newborn screening program, 2013–2019
  6. Analysis of the CAG tract length in the Androgen Receptor gene in Mexican patients with nonsyndromic cryptorchidism
  7. Pituitary hypoplasia is the best MRI predictor of the severity and type of growth hormone deficiency in children with congenital growth hormone deficiency
  8. Urinary gonadotropin measurements by enhanced luminometric assays (LIA) for the evaluation of pubertal development
  9. Challenges in management of transient hyperinsulinism – a retrospective analysis of 36 severely affected children
  10. Who should return for an oral glucose tolerance test? A proposed clinical pathway based on retrospective analysis of 332 children
  11. Investigation of the prevalence of cardiovascular risk factors in obese patients diagnosed with metabolic syndrome in childhood and examination of left ventricular function by echocardiography
  12. Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial
  13. Management of patients with X-linked hypophosphatemic rickets during Covid-19 pandemic lockdown
  14. Evaluation of the pathophysiological role of Fetuin A levels in adolescents with polycystic ovary syndrome
  15. Gonadotropins for testicular descent in cryptorchid congenital hypogonadotropic hypogonadism males beyond infancy
  16. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt
  17. Letter to the Editor
  18. Revisiting the effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria
  19. Case Reports
  20. Pulmonary and cutaneous mucormycosis in two children with diabetes mellitus type 1
  21. Pyruvate carboxylase deficiency type C as a differential diagnosis of diabetic ketoacidosis
  22. Barth syndrome with severe dilated cardiomyopathy and growth hormone resistance: a case report
  23. The utility of reverse phenotyping: a case of lysinuric protein intolerance presented with childhood osteoporosis
Downloaded on 3.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2020-0378/html
Scroll to top button